OrthoPediatrics Corp. $KIDS Shares Acquired by Granahan Investment Management LLC

Granahan Investment Management LLC boosted its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 35.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 896,741 shares of the company’s stock after buying an additional 232,760 shares during the period. Granahan Investment Management LLC’s holdings in OrthoPediatrics were worth $14,231,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the business. Roubaix Capital LLC lifted its stake in OrthoPediatrics by 23.8% in the 1st quarter. Roubaix Capital LLC now owns 290,047 shares of the company’s stock worth $4,603,000 after acquiring an additional 55,724 shares in the last quarter. Wasatch Advisors LP lifted its stake in OrthoPediatrics by 13.6% in the first quarter. Wasatch Advisors LP now owns 329,320 shares of the company’s stock valued at $5,226,000 after acquiring an additional 39,451 shares during the last quarter. Triodos Investment Management BV boosted its holdings in OrthoPediatrics by 10.9% in the fourth quarter. Triodos Investment Management BV now owns 147,000 shares of the company’s stock worth $2,640,000 after purchasing an additional 14,500 shares in the last quarter. FourThought Financial Partners LLC bought a new stake in shares of OrthoPediatrics during the 4th quarter worth about $197,000. Finally, Tudor Investment Corp ET AL grew its holdings in OrthoPediatrics by 36.6% during the third quarter. Tudor Investment Corp ET AL now owns 70,935 shares of the company’s stock valued at $1,314,000 after purchasing an additional 19,004 shares during the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Truist Financial raised their price target on OrthoPediatrics from $17.00 to $20.00 and gave the company a “hold” rating in a research report on Thursday, July 16th. TD Cowen restated a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. BTIG Research restated a “buy” rating and set a $24.00 target price on shares of OrthoPediatrics in a research report on Friday, May 1st. Canaccord Genuity Group set a $25.00 price target on shares of OrthoPediatrics in a research report on Friday, April 24th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of OrthoPediatrics in a report on Friday, July 17th. Nine investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, OrthoPediatrics presently has an average rating of “Moderate Buy” and an average target price of $24.78.

OrthoPediatrics Trading Up 0.8%

KIDS opened at $18.87 on Friday. The firm’s fifty day moving average is $18.81 and its two-hundred day moving average is $17.75. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.37 and a current ratio of 5.21. The firm has a market cap of $484.58 million, a PE ratio of -11.23 and a beta of 0.99. OrthoPediatrics Corp. has a twelve month low of $14.42 and a twelve month high of $23.07.

OrthoPediatrics (NASDAQ:KIDS) last announced its quarterly earnings results on Thursday, April 30th. The company reported ($0.42) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.46) by $0.04. OrthoPediatrics had a negative return on equity of 7.01% and a negative net margin of 16.31%.The company had revenue of $59.36 million during the quarter, compared to the consensus estimate of $58.28 million. Equities research analysts anticipate that OrthoPediatrics Corp. will post -1.13 EPS for the current year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.